{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:45:35Z","timestamp":1761709535701,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jocd.2018.07.010","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T02:22:31Z","timestamp":1534126951000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Does the Antitumor Necrosis Factor-\u03b1 Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?"],"prefix":"10.1016","volume":"22","author":[{"given":"M.B.","family":"Maldonado-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Castro-Laria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Caunedo-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Montoya-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Giner-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Arg\u00fcelles-Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u00c1.","family":"V\u00e1zquez-G\u00e1mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jocd.2018.07.010_bib0001","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00054725-200608000-00016","article-title":"Prevention and treatment of osteoporosis in inflammatory bowel disease","volume":"12","author":"Lichtenstein","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.jocd.2018.07.010_bib0002","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MEG.0b013e3282f8888b","article-title":"High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease","volume":"20","author":"Heijckmann","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jocd.2018.07.010_bib0003","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease","volume":"51","author":"Klaus","year":"2002","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jocd.2018.07.010_bib0004","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cgh.2007.02.024","article-title":"Vertebral fractures and role of low bone mineral density in Crohn's disease","volume":"5","author":"Siffledeen","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jocd.2018.07.010_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-230X-12-47","article-title":"Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study","volume":"12","author":"Vazquez","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.jocd.2018.07.010_bib0006","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00198-012-2141-4","article-title":"Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome","volume":"24","author":"Stobaugh","year":"2013","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.jocd.2018.07.010_bib0007","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/MEG.0b013e3282f8889f","article-title":"Vertebral deformities and inflammatory bowel disease","volume":"20","author":"Stokkers","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jocd.2018.07.010_bib0008","unstructured":"Neyro Bilbao JL Palacios Gil-Antu\u00f1ano S. Cano Sanchez A. Regulaci\u00f3n del metabolismo \u00f3seo a trav\u00e9s del sistema RANK-RANKL-OPG. Rev Osteoporos Metab. 2011:105\u2013112."},{"issue":"8","key":"10.1016\/j.jocd.2018.07.010_bib0009","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1572-0241.2003.07590.x","article-title":"The association between corticosteroid use and development of fractures among IBD patients in a population-based database","volume":"98","author":"Bernstein","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"46","key":"10.1016\/j.jocd.2018.07.010_bib0010","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.3748\/wjg.v13.i46.6156","article-title":"Basic and clinical aspects of osteoporosis in inflammatory bowel disease","volume":"13","author":"Rodriguez-Bores","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jocd.2018.07.010_bib0011","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ibd.20234","article-title":"Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy","volume":"13","author":"Miheller","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.jocd.2018.07.010_bib0012","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2011.04667.x","article-title":"Review article: the effects of antitumour necrosis factor-\u03b1 on bone metabolism in inflammatory bowel disease","volume":"33","author":"Veerappan","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jocd.2018.07.010_bib0013","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/ard.2005.044198","article-title":"Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis","volume":"65","author":"Vis","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"9317","key":"10.1016\/j.jocd.2018.07.010_bib0014","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2018.07.010_bib0015","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1046\/j.1440-1746.17.s1.1.x","article-title":"A critical assessment of new therapies in inflammatory bowel disease","volume":"17","author":"Rutgeerts","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jocd.2018.07.010_bib0016","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","article-title":"Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study","volume":"128","author":"Jarnerot","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jocd.2018.07.010_bib0017","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jocd.2018.07.010_bib0018","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/BOR.0b013e328356d212","article-title":"Effects of anti-tumor necrosis factor alpha agents on bone","volume":"24","author":"Kawai","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.jocd.2018.07.010_bib0019","first-page":"663","article-title":"Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy","volume":"2","author":"Marotte","year":"2008","journal-title":"Biologics"},{"issue":"9","key":"10.1016\/j.jocd.2018.07.010_bib0020","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2005.50219.x","article-title":"Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease","volume":"100","author":"Bernstein","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"1\u20132","key":"10.1016\/j.jocd.2018.07.010_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000091299","article-title":"Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease","volume":"24","author":"Miheller","year":"2006","journal-title":"Dig Dis"},{"issue":"9","key":"10.1016\/j.jocd.2018.07.010_bib0022","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jocd.2018.07.010_bib0023","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","article-title":"Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group","volume":"11","author":"Genant","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2018.07.010_bib0024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1359\/jbmr.1999.14.1.90","article-title":"Defining incident vertebral deformity: a prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.jocd.2018.07.010_bib0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","article-title":"Biologic therapies and systemic bone loss in rheumatoid arthritis","volume":"12","author":"Dimitroulas","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.jocd.2018.07.010_bib0026","doi-asserted-by":"crossref","first-page":":R179","DOI":"10.1186\/ar4368","article-title":"Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes","volume":"15","author":"Klingberg","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jocd.2018.07.010_bib0027","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ejim.2017.01.024","article-title":"Influence of anti-TNF therapy on bone metabolism in patients with inflammatory bowel disease","volume":"39","author":"Castro","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jocd.2018.07.010_bib0028","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1196\/annals.1351.040","article-title":"Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis","volume":"1069","author":"Seriolo","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.jocd.2018.07.010_bib0029","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ibd.20234","article-title":"Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy","volume":"13","author":"Miheller","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.jocd.2018.07.010_bib0030","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/MIB.0b013e31828075a7","article-title":"Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset","volume":"19","author":"Azzopardi","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.jocd.2018.07.010_bib0031","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1568010054022015","article-title":"Osteoblasts and osteoclasts in bone remodeling and inflammation","volume":"4","author":"Tanaka","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"4","key":"10.1016\/j.jocd.2018.07.010_bib0032","first-page":"663","article-title":"Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNF\u03b1 therapy","volume":"2","author":"Marotte","year":"2008","journal-title":"Biol Targets Ther"},{"issue":"10","key":"10.1016\/j.jocd.2018.07.010_bib0033","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jocd.2018.07.010_bib0034","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/gast.2002.34779","article-title":"Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota","volume":"123","author":"Loftus","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jocd.2018.07.010_bib0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s005350300042","article-title":"Quantitative ultrasound of the proximal phalanges and dual-energy X-ray absorptiometry in Crohn's disease patients with osteopenia","volume":"38","author":"von Tirpitz","year":"2003","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jocd.2018.07.010_bib0036","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004424-197611000-00007","article-title":"Skeletal demineralization and growth retardation in inflammatory bowel disease","volume":"11","author":"Genant","year":"1976","journal-title":"Invest Radiol"},{"issue":"2","key":"10.1016\/j.jocd.2018.07.010_bib0037","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/gut.46.2.176","article-title":"Fracture risk is increased in Crohn's disease, but not in ulcerative colitis","volume":"46","author":"Vestergaard","year":"2000","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.jocd.2018.07.010_bib0038","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3899\/jrheum.100363","article-title":"Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases\u2014a case-control study with 53,108 patients with fracture","volume":"37","author":"Weiss","year":"2010","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.jocd.2018.07.010_bib0039","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1046\/j.1365-2036.2002.01317.x","article-title":"Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease","volume":"16","author":"Stockbrugger","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jocd.2018.07.010_bib0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4158\/EP.12.6.622","article-title":"Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review","volume":"12","author":"Sinnott","year":"2006","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.jocd.2018.07.010_bib0041","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar4581","article-title":"Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis","volume":"16","author":"Kang","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.jocd.2018.07.010_bib0042","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2018.07.010_bib0043","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.abb.2010.06.026","article-title":"Inflammatory bowel diseases, celiac disease, and bone","volume":"503","author":"Bianchi","year":"2010","journal-title":"Arch Biochem Biophys"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695018300738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695018300738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:41:52Z","timestamp":1761082912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695018300738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1094695018300738"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2018.07.010","relation":{},"ISSN":["1094-6950"],"issn-type":[{"type":"print","value":"1094-6950"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the Antitumor Necrosis Factor-\u03b1 Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2018.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}